Is AIQUY a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Air Liquide (AIQUY) rests on Industrial gases is a structurally attractive business: Gases are expensive to transport relative to their value, so suppliers build production on or near the customer's site under contracts running fifteen years or more. The bear case rests on industrial gas demand tracks industrial production, so a manufacturing slowdown reduces volumes; trailing revenue grew less than 1% year over year in the latest quarter. Analysts covering it publish targets from $43.00 to $46.80 against a $38.76 price, so even the professionals disagree by 8% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Air Liquide is a French industrial gases company supplying oxygen, nitrogen, hydrogen and specialty gases to industry, healthcare and electronics manufacturing, typically under long-term contracts with on-site production. It employs about 65,000 people and generated roughly €27 billion of revenue over the trailing twelve months to June 2026, with net income of about €3.5 billion, an operating margin near 20% and a net margin near 13%. Revenue has been roughly flat for three years (about €27.1 billion in 2024 and €26.9 billion in 2025) as lower energy costs were passed through to customers, while net profit kept rising, from about €3.1 billion in 2023 to €3.5 billion in 2025. Air Liquide is a defensive industrial with contracted volumes and pricing power, valued accordingly. On October 5, 2026, at its Capital Markets Day, the company launched a plan called BEYOND running to 2030. Its targets: sales growth of about 5% a year (plus or minus one point), recurring net EPS growth of about 10% a year from end-2025 to end-2030, a cumulative operating margin improvement of 400 to 600 basis points over 2026-2030, and recurring return on capital employed above 11% in 2030. It plans to allocate more than €40 billion over the period, including about €24 billion of industrial investment decisions, continued dividend growth and a first-ever €4 billion share buyback over 2027-2028. Priority markets are electronics and AI (electronics sales targeted to grow more than 10% a year), the energy transition, healthcare and space. Activist fund Elliott Management, which says it holds a significant economic interest, called the plan a positive first step, said the buyback should start immediately, and wants Air Liquide to close its margin and valuation gaps with peers. The ADR has been range-bound: up about 4.5% year to date but down about 3.4% over one year as of October 16, 2026, within a 52-week range of roughly $36 to $44.
The bull case: what would have to be true for $46.80
The most optimistic published target on AIQUY is $46.80, +20.7% from the $38.76 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
Industrial gases is a structurally attractive business
Gases are expensive to transport relative to their value, so suppliers build production on or near the customer's site under contracts running fifteen years or more. That creates local near-monopolies, predictable volumes and high barriers to entry. New capacity keeps following that model; in October 2026 Air Liquide announced a new air separation unit at its Fairfield facility in New South Wales, Australia.
Margin catch-up under the 2030 plan
Air Liquide's margins have trailed its closest peer, Linde, and closing that gap is now an explicit target: 400 to 600 basis points of cumulative operating margin improvement over 2026-2030 and recurring ROCE above 11% by 2030. Combined with about 5% annual sales growth and a €4 billion buyback, management targets about 10% annual growth in recurring EPS. Elliott Management's involvement adds outside pressure to deliver, and its view that the targets leave room for outperformance sets a high bar.
Hydrogen for the energy transition
Air Liquide is one of the largest industrial hydrogen producers and is investing in low-carbon hydrogen, with the energy transition named as one of four priority markets in the 2030 plan. Whether that becomes a major profit engine depends on policy support and on customers paying a premium for cleaner supply. The company reaffirmed targets to cut Scope 1 and 2 CO2 emissions 33% by 2035 versus 2020 and reach carbon neutrality by 2050.
Electronics and healthcare demand
Semiconductor fabrication consumes large volumes of specialty gases, and AI-driven chip investment is why Air Liquide targets electronics sales growth above 10% a year through 2030. Medical oxygen supply is a steady, regulated business. Both are less cyclical than heavy industry.
The bear case: what would have to be true for $43.00
The most pessimistic published target is $43.00, +10.9% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Air Liquide is worth if the risks below bite instead of the drivers above.
Industrial gas demand tracks industrial production, so a manufacturing slowdown reduces volumes; trailing revenue grew less than 1% year over year in the latest quarter. The business is energy-intensive, and electricity and natural gas costs are a major input that must be passed through. Large hydrogen projects require substantial capital with returns dependent on policy that can change, and the 2030 plan steps up investment to about €24 billion of industrial decisions. Debt is about €17 billion against roughly €2 billion of cash, and trailing free cash flow was thin relative to operating cash flow because of heavy capital spending. The valuation (about 30 times trailing earnings) already assumes steady growth, so missing the new margin targets with an activist shareholder on the register could weigh on the shares. As a French company, US investors hold an over-the-counter ADR exposed to euro movements and with less liquidity than the Paris listing.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding AIQUY already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on AIQUY
3 analysts cover AIQUY, with an average target of $44.93 (+15.9% against $38.76) and a split of 3 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the AIQUY forecast and price target page.
How is AIQUY valued? (as of October 2026)
Snapshot for AIQUY as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~€27B (up ~0.8% YoY in the latest quarter)
- Net income (TTM): ~€3.5B; net margin ~13%, operating margin ~20%
- Market cap: ~$124B (ADR ~$38.94 on October 16, 2026)
- P/E (trailing / forward): ~30x / ~24x
- Dividend: ~$0.78 per ADR a year, ~2.0% yield
- 2030 plan targets: Sales ~+5%/yr, recurring EPS ~+10%/yr, +400-600 bps operating margin, ROCE >11%, €4B buyback 2027-2028
- Business model: Industrial gases under long-term on-site and pipeline contracts, frequently fifteen years or more
- Listing: US-traded OTC ADR of a French company; exposed to euro moves
Air Liquide is a defensive industrial with contracted volumes and pricing power, valued at about 30 times trailing and 24 times forward earnings, a premium multiple that rests on steady compounding rather than fast growth. The October 2026 plan adds explicit margin, EPS and buyback targets, which could support the valuation if delivered. Analysts expect 2026 EPS growth of about 5% and 2027 growth of about 12%; verify current margins, energy pass-through and the capital committed to hydrogen projects.
How do you decide if AIQUY is a buy?
Rather than asking whether AIQUY is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold AIQUY indirectly through an index or sector ETF before adding more.
What would change your mind on AIQUY
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Industrial gases is a structurally attractive business stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: industrial gas demand tracks industrial production, so a manufacturing slowdown reduces volumes; trailing revenue grew less than 1% year over year in the latest quarter fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the AIQUY stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about AIQUY against your real portfolio and see your actual exposure before deciding.
Investing in Air Liquide with AI
Connect the broker you already use and ask Walnut's AI how AIQUY fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is AIQUY a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Industrial gases is a structurally attractive business, with revenue (ttm) at ~€27B (up ~0.8% YoY in the latest quarter). The bear case rests on industrial gas demand tracks industrial production, so a manufacturing slowdown reduces volumes; trailing revenue grew less than 1% year over year in the latest quarter. Analysts covering it are spread from $43.00 to $46.80, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell AIQUY?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Industrial gas demand tracks industrial production, so a manufacturing slowdown reduces volumes; trailing revenue grew less than 1% year over year in the latest quarter. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $43.00, +10.9% from the $38.76 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for AIQUY?
+
Industrial gases is a structurally attractive business. Gases are expensive to transport relative to their value, so suppliers build production on or near the customer's site under contracts running fifteen years or more. The most optimistic analyst target on AIQUY is $46.80, +20.7% from the $38.76 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for AIQUY?
+
Industrial gas demand tracks industrial production, so a manufacturing slowdown reduces volumes; trailing revenue grew less than 1% year over year in the latest quarter. The business is energy-intensive, and electricity and natural gas costs are a major input that must be passed through. Large hydrogen projects require substantial capital with returns dependent on policy that can change, and the 2030 plan steps up investment to about €24 billion of industrial decisions. Debt is about €17 billion against roughly €2 billion of cash, and trailing free cash flow was thin relative to operating cash flow because of heavy capital spending. The valuation (about 30 times trailing earnings) already assumes steady growth, so missing the new margin targets with an activist shareholder on the register could weigh on the shares. As a French company, US investors hold an over-the-counter ADR exposed to euro movements and with less liquidity than the Paris listing. The most pessimistic published target is $43.00, +10.9% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Air Liquide do?
+
Air Liquide is a French industrial gases company supplying oxygen, nitrogen, hydrogen and specialty gases to industry, healthcare and electronics manufacturing, typically under lon
What would have to change for AIQUY to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Industrial gases is a structurally attractive business) stalling in the reported numbers rather than in the narrative, the risk above (industrial gas demand tracks industrial production, so a manufacturing slowdown reduces volumes; trailing revenue grew less than 1% year over year in the latest quarter) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Air Liquide do?
+
Air Liquide is a French industrial gases company supplying oxygen, nitrogen, hydrogen and specialty gases to industry, healthcare and electronics manufacturing, typically under long-term contracts with on-site production. It has about 65,000 employees and roughly €27 billion of annual revenue.
Is AIQUY a good stock to buy?
+
That depends on your thesis, time horizon and what you already hold, not on any single call. The case (contracted volumes, a new 2030 plan with margin and buyback targets) and the risks (premium valuation, industrial cyclicality, heavy investment) are both set out on this page. Walnut is informational and not a registered investment adviser, so treat this as research rather than a recommendation.
Who competes with Air Liquide?
+
Industrial gases: Linde is the largest global competitor and the closest comparison on business model and margins. Air Products competes globally with a heavier weighting toward large hydrogen and gasification projects. Regional and on-site suppliers: Smaller regional players compete for local packaged-gas business, though the on-site and pipeline segments are effectively closed once a supplier builds at a customer's plant.
Walnut is informational, not investment advice, and gives no verdict on AIQUY. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.
Guides that feature AIQUY
AIQUY is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.